William C Brintnell Selected Research

C-galactosylceramide

7/2012

Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William C Brintnell Research Topics

Disease

2	Infections 01/2015 - 01/2014
2	Onychomycosis (Tinea Unguium) 01/2014 - 07/2013
1	Tinea Pedis (Athlete's Foot) 07/2013
1	Reinfection 07/2013
1	Rheumatoid Arthritis 07/2012
1	Arthritis (Polyarthritis) 07/2012

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 07/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2015
1	dectin 1IBA 01/2014
1	OzoneIBA 07/2013
1	LigandsIBA 07/2012
1	C-galactosylceramideIBA 07/2012
1	GlycolipidsIBA 07/2012
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 07/2012
1	CitrullineIBA 07/2012

Therapy/Procedure

1	Home Nursing (Nursing, Home) 01/2015
1	Therapeutics 07/2013